ConductScience.org, home

Paper16632085

Use of the cumulative proportion of responders analysis graph to present pain data over a range of cut-off points: making clinical trial data more understandable.

Farrar JT and 2 others. J Pain Symptom Manage, 2006. Cited by 110 papers, by iCite.

Cite this record

ConductScience Library. Use of the cumulative proportion of responders analysis graph to present pain data over a range of cut-off points: making clinical trial data more understandable. Papers, record 16632085. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16632085

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Use of the cumulative proportion of responders analysis graph to present pain data over a range of cut-off points: making clinical trial data more understandable.
PubMed
Journal
J Pain Symptom Manage
PubMed
Year
2006
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
110
iCite
Relative citation ratio, by iCite
3.75
iCite
Revised in PubMed
2022-04-08
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Farrar JTJohn T
2Dworkin RHRobert H
3Max MBMitchell B

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AnalgesicsMajor topic
Outcome Assessment, Health CareMajor topic
PainMajor topic
Clinical Trials as Topic
Data Display
Data Interpretation, Statistical
Humans
Pain Measurement

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
KO8-NS01865NINDS NIH HHSUnited StatesK08NS001865PubMed and NIHNIH RePORTER
R01-CA73797NCI NIH HHSUnited StatesR01CA073797PubMed and NIHNIH RePORTER
Z01DE000366NIHNIH RePORTER

Download CSV of grants

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in18655954Re: cumulative proportion of responders.https://conductscience.org/library/papers/18655954

Source PubMed

Download CSV of comments and corrections

Cited by51

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 110 citations.

PMIDTitleJournalYearIn PapersSource
42501111Effects of Terminalia fagifolia mart. extract combined with photobiomodulation on diabetic foot ulcers: protocol for a randomized single-blind clinical trial.Lasers Med Sci2026https://conductscience.org/library/papers/42501111PubMed
41396210Dual-Polymer Carboxymethyl Cellulose and Poly(Ethylene Oxide) Gel Reduces Leg and Back Pain in Patients With Severe Leg and Back Pain Following Single-Level Partial Discectomy.Spine (Phila Pa 1976)2026https://conductscience.org/library/papers/41396210PubMed
41028567Dose-response and efficacy of 660-nanometer low-level laser therapy in healing diabetic foot ulcers: a randomized, double-blind, clinical trial.Lasers Med Sci2025https://conductscience.org/library/papers/41028567PubMed
41021046Dose-response and efficacy of 830-nanometer photobiomodulation in healing diabetic foot ulcers: randomized, double-blind, clinical trial protocol.Lasers Med Sci2025https://conductscience.org/library/papers/41021046PubMed
39137167Oral resveratrol in adults with knee osteoarthritis: A randomized placebo-controlled trial (ARTHROL).PLoS Med2024https://conductscience.org/library/papers/39137167PubMed
38805069Dose-response and efficacy of 904 nm photobiomodulation on diabetic foot ulcers healing: a randomized controlled trial.Lasers Med Sci2024https://conductscience.org/library/papers/38805069PubMed
37519369Comparison of false positive and false negative rates of two indices of individual reliable change: Jacobson-Truax and Hageman-Arrindell methods.Front Psychol2023https://conductscience.org/library/papers/37519369PubMed
37274016Statistical Evaluation of Absolute Change versus Responder Analysis in Clinical Trials.Acta Mater Med2022https://conductscience.org/library/papers/37274016PubMed
37231386Effectiveness of spinal manipulation and biopsychosocial self-management compared to medical care for low back pain: a randomized trial study protocol.BMC Musculoskelet Disord2023https://conductscience.org/library/papers/37231386PubMed
37205428Effectiveness of Spinal Manipulation and Biopsychosocial Self-Management compared to Medical Care for Low Back Pain: A Randomized Trial Study Protocol.Res Sq2023https://conductscience.org/library/papers/37205428PubMed
36766649The Immediate Hypoalgesic Effect of Low and High Force Thoracic Mobilizations in Asymptomatic Subjects as Measured by Pain Pressure Thresholds (PPT).Diagnostics (Basel)2023https://conductscience.org/library/papers/36766649PubMed
36107505Fast pain relief in exercise-induced acute musculoskeletal pain by turmeric-boswellia formulation: A randomized placebo-controlled double-blinded multicentre study.Medicine (Baltimore)2022https://conductscience.org/library/papers/36107505PubMed
35669038The Effectiveness and Safety of Medical Cannabis for Treating Cancer Related Symptoms in Oncology Patients.Front Pain Res (Lausanne)2022https://conductscience.org/library/papers/35669038PubMed
35263346Outcomes of a controlled trial with visiting therapy dog teams on pain in adults in an emergency department.PLoS One2022https://conductscience.org/library/papers/35263346PubMed
35232482Multidisciplinary integrative care versus chiropractic care for low back pain: a randomized clinical trial.Chiropr Man Therap2022https://conductscience.org/library/papers/35232482PubMed
34534176An implantable restorative-neurostimulator for refractory mechanical chronic low back pain: a randomized sham-controlled clinical trial.Pain2021https://conductscience.org/library/papers/34534176PubMed
33521483Essential statistical principles of clinical trials of pain treatments.Pain Rep2021https://conductscience.org/library/papers/33521483PubMed
33470748
Research design considerations for randomized controlled trials of spinal cord stimulation for pain: Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials/Institute of Neuromodulation/International Neuromodulation Society recommendations.
Pain2021https://conductscience.org/library/papers/33470748PubMed
32701836Efficacy and safety of propranolol for treatment of temporomandibular disorder pain: a randomized, placebo-controlled clinical trial.Pain2020https://conductscience.org/library/papers/32701836PubMed
32520773Interpretation of chronic pain clinical trial outcomes: IMMPACT recommended considerations.Pain2020https://conductscience.org/library/papers/32520773PubMed

See all 51 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/16632085

GET https://conductscience.org/api/papers/v1/16632085/cited_by?page=2